Europe Moves To Suspend Merck Cholesterol Drug
By Rachel Slajda ( January 18, 2013, 6:55 PM EST) -- The European Medicines Agency announced Friday that it had confirmed a recommendation to suspend a cholesterol drug treatment by Merck Sharp & Dohme Ltd. after concluding that the drug's benefits don't outweigh the risks....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.